Published data from Moderna COVID-19 vaccine trial show 94.1 percent efficacy
A peer-reviewed paper published in The New England Journal of Medicine provides data from the much-anticipated COVE study, which evaluated mRNA-1273, a vaccine candidate against COVID-19 manufactured by Moderna, Inc. Results ...
Dec 31, 2020
0
745
